Search details
1.
A phase II trial of nifurtimox combined with topotecan and cyclophosphamide for refractory or relapsed neuroblastoma and medulloblastoma.
Int J Cancer
; 153(5): 1026-1034, 2023 Sep 01.
Article
in English
| MEDLINE | ID: mdl-37246577
2.
Consensus recommendations in the management of Ewing sarcoma from the National Ewing Sarcoma Tumor Board.
Cancer
; 129(21): 3363-3371, 2023 Nov 01.
Article
in English
| MEDLINE | ID: mdl-37403815
3.
Phase II trial of gemcitabine and nab-paclitaxel in patients with recurrent Ewing sarcoma: A report from the National Pediatric Cancer Foundation.
Pediatr Blood Cancer
; 67(7): e28370, 2020 07.
Article
in English
| MEDLINE | ID: mdl-32386107
4.
Factors influencing survival after recurrence in osteosarcoma: A report from the Children's Oncology Group.
Pediatr Blood Cancer
; 66(1): e27444, 2019 01.
Article
in English
| MEDLINE | ID: mdl-30255612
5.
A phase II study of eribulin in recurrent or refractory osteosarcoma: A report from the Children's Oncology Group.
Pediatr Blood Cancer
; 66(2): e27524, 2019 02.
Article
in English
| MEDLINE | ID: mdl-30378256
6.
Consensus and controversies regarding the treatment of rhabdomyosarcoma.
Pediatr Blood Cancer
; 65(2)2018 Feb.
Article
in English
| MEDLINE | ID: mdl-28905489
7.
Treatment pathway of bone sarcoma in children, adolescents, and young adults.
Cancer
; 123(12): 2206-2218, 2017 Jun 15.
Article
in English
| MEDLINE | ID: mdl-28323337
8.
Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial.
Lancet Oncol
; 17(10): 1396-1408, 2016 Oct.
Article
in English
| MEDLINE | ID: mdl-27569442
9.
An evolutionary framework for treating pediatric sarcomas.
Cancer
; 126(11): 2577-2587, 2020 06 01.
Article
in English
| MEDLINE | ID: mdl-32176331
10.
Clinical features and outcomes of infants with Ewing sarcoma under 12 months of age.
Pediatr Blood Cancer
; 62(11): 1947-51, 2015 Nov.
Article
in English
| MEDLINE | ID: mdl-26173989
11.
Primary Cutaneous Follicle Center Lymphoma in a 16-Year-old boy With Crohn Disease Exposed to Infliximab and Methotrexate.
J Pediatr Gastroenterol Nutr
; 70(2): e49-e50, 2020 02.
Article
in English
| MEDLINE | ID: mdl-31978035
12.
A phase II trial of a multi-agent oral antiangiogenic (metronomic) regimen in children with recurrent or progressive cancer.
Pediatr Blood Cancer
; 61(4): 636-42, 2014 Apr.
Article
in English
| MEDLINE | ID: mdl-24123865
13.
Bilateral tonic pupils secondary to anti-GD2 antibody therapy for neuroblastoma.
J AAPOS
; 28(2): 103852, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-38368925
14.
Eflornithine as Postimmunotherapy Maintenance in High-Risk Neuroblastoma: Externally Controlled, Propensity Score-Matched Survival Outcome Comparisons.
J Clin Oncol
; 42(1): 90-102, 2024 Jan 01.
Article
in English
| MEDLINE | ID: mdl-37883734
15.
Molecular-guided therapy for the treatment of patients with relapsed and refractory childhood cancers: a Beat Childhood Cancer Research Consortium trial.
Genome Med
; 16(1): 28, 2024 Feb 12.
Article
in English
| MEDLINE | ID: mdl-38347552
16.
Phase 2 trial of clofarabine in combination with etoposide and cyclophosphamide in pediatric patients with refractory or relapsed acute lymphoblastic leukemia.
Blood
; 118(23): 6043-9, 2011 Dec 01.
Article
in English
| MEDLINE | ID: mdl-21967976
17.
Poor survival for osteosarcoma of the pelvis: a report from the Children's Oncology Group.
Clin Orthop Relat Res
; 470(7): 2007-13, 2012 Jul.
Article
in English
| MEDLINE | ID: mdl-22354612
18.
Phase 2 study of anti-disialoganglioside antibody, dinutuximab, in combination with GM-CSF in patients with recurrent osteosarcoma: A report from the Children's Oncology Group.
Eur J Cancer
; 172: 264-275, 2022 Sep.
Article
in English
| MEDLINE | ID: mdl-35809374
19.
A Phase I Trial of TB-403 in Relapsed Medulloblastoma, Neuroblastoma, Ewing Sarcoma, and Alveolar Rhabdomyosarcoma.
Clin Cancer Res
; 28(18): 3950-3957, 2022 09 15.
Article
in English
| MEDLINE | ID: mdl-35833850
20.
A pilot study of genomic-guided induction therapy followed by immunotherapy with difluoromethylornithine maintenance for high-risk neuroblastoma.
Cancer Rep (Hoboken)
; 5(11): e1616, 2022 11.
Article
in English
| MEDLINE | ID: mdl-35355452